microRNA-205 Regulates HER3 in Human Breast Cancer
- 15 March 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (6), 2195-2200
- https://doi.org/10.1158/0008-5472.can-08-2920
Abstract
An increasing amount of experimental evidence shows that microRNAs can have a causal role in breast cancer tumorigenesis as a novel class of oncogenes or tumor suppressor genes, depending on the targets they regulate. HER2 overexpression is a hallmark of a particularly aggressive subset of breast tumors, and its activation is strictly dependent on the trans-interaction with other members of HER family; in particular, the activation of the PI3K/Akt survival pathway, so critically important in tumorigenesis, is predominantly driven through phosphorylation of the kinase-inactive member HER3. Here, we show that miR-205, down-modulated in breast tumors compared with normal breast tissue, directly targets HER3 receptor, and inhibits the activation of the downstream mediator Akt. The reintroduction of miR-205 in SKBr3 cells inhibits their clonogenic potential and increases the responsiveness to tyrosine-kinase inhibitors Gefitinib and Lapatinib, abrogating the HER3-mediated resistance and restoring a potent proapoptotic activity. Our data describe miR-205 as a new oncosuppressor gene in breast cancer, able to interfere with the proliferative pathway mediated by HER receptor family. Our study also provides experimental evidence suggesting that miR-205 can improve the responsiveness to specific anticancer therapies. [Cancer Res 2009;69(6):2195–200]Keywords
Other Versions
This publication has 20 references indexed in Scilit:
- MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancerEuropean Journal of Cancer, 2008
- Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast CancerCancer Research, 2007
- A sensitive procedure to detect alternatively spliced mRNA in pooled-tissue samplesNucleic Acids Research, 2007
- Targeting HER proteins in cancer therapy and the role of the non-target HER3British Journal of Cancer, 2007
- Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3Nature, 2007
- miRGen: a database for the study of animal microRNA genomic organization and functionNucleic Acids Research, 2006
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell TumorsCell, 2006
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- RAS Is Regulated by the let-7 MicroRNA FamilyCell, 2005